| Residential College | false |
| Status | 已發表Published |
| Problem Behaviours and Their Management in Intellectual Disability: A Multi-National Cross-Sectional Survey | |
Perry, B. I. ; Cooray, S.; Mendis, J.; Purandare, K.; Wijeratne, A.; Manjubhashini, S.; Dasari, M.; Esan, F.; Gunaratna, I.; Naseem, R. A. ; Hoare, S.; Chester, V.; Roy, A.; Devapriam, J.; Alexander, R. T. ; Kwok, H. F.
| |
| 2018-02-02 | |
| Source Publication | Journal of Intellectual Disability Research
 |
| ISSN | 1365-2788 |
| Pages | 140-149 |
| Abstract | Background Problem behaviours (PBs) are a common cause for clinician contact in people with disorders of intellectual development (PWDID), and may be a common cause for the prescription of psychotropic medication. We aimed to use a large, multi-national sample to define the prevalence of PBs, the associations with psychotropic medication use, and to assess for any potential ‘diagnostic overshadowing’ by the label of PBs in a population of PWDID. Method A multi-national, multi-setting, cross-sectional service evaluation and baseline audit was completed. Data was collected from U.K. hospitals, U.K. community settings, Sri Lanka, and Hong Kong. A semi-structured questionnaire was completed by treating clinicians, capturing demographic details, prevalence rates of intellectual disability and psychotropic medication use, alongside psychiatric co-morbidity. Results A sample size of 358 was obtained, with 65% of included participants treated in an inpatient setting. Psychotropic use was prevalent (90%) in our sample, particularly antipsychotics (74%). The prevalence of PB was high (83%). There was no statistically significant association between psychotropic prescription and recorded psychiatric comorbidity, suggesting prevalent ‘off label’ use for PBs, or poor recording of psychiatric comorbidity. There was some evidence of possible diagnostic overshadowing due to the PB classification. A higher dose of psychotropic medication was associated with aggression toward others (p=0.03). Conclusions We found evidence of prevalent potential ‘off-label’ use for psychotropic medication, which may be due to PBs. We also found evidence of potential diagnostic-overshadowing, where symptoms of psychiatric comorbidity may have been attributed to PBs. Our findings provide renewed importance, across borders and health systems, for clinicians to consider a holistic approach to treating PBs, and attempting to best understand the precipitants and predisposing factors before psychotropic prescribing. |
| Keyword | Intellectual Disability Problem Behaviours Psychotropic Medication International |
| Language | 英語English |
| The Source to Article | PB_Publication |
| PUB ID | 35488 |
| Document Type | Journal article |
| Collection | DEPARTMENT OF BIOMEDICAL SCIENCES |
| Corresponding Author | Perry, B. I. |
| Recommended Citation GB/T 7714 | Perry, B. I.,Cooray, S.,Mendis, J.,et al. Problem Behaviours and Their Management in Intellectual Disability: A Multi-National Cross-Sectional Survey[J]. Journal of Intellectual Disability Research, 2018, 140-149. |
| APA | Perry, B. I.., Cooray, S.., Mendis, J.., Purandare, K.., Wijeratne, A.., Manjubhashini, S.., Dasari, M.., Esan, F.., Gunaratna, I.., Naseem, R. A. ., Hoare, S.., Chester, V.., Roy, A.., Devapriam, J.., Alexander, R. T. ., & Kwok, H. F. (2018). Problem Behaviours and Their Management in Intellectual Disability: A Multi-National Cross-Sectional Survey. Journal of Intellectual Disability Research, 140-149. |
| MLA | Perry, B. I.,et al."Problem Behaviours and Their Management in Intellectual Disability: A Multi-National Cross-Sectional Survey".Journal of Intellectual Disability Research (2018):140-149. |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment